IFOM ETS - The AIRC Institute of Molecular Oncology

OrganizationROROpenAlex

Trials

  • NCT06490536

    Phase 3, Recruiting, 700 people, Jul 8, 2024

  • NCT04248998

    Collaborator, Phase 2, Status unknown, 30 people, Jan 30, 2020

  • NCT03589014

    Collaborator, Phase 2, Completed, 71 people, Jul 17, 2018

  • NCT03519412

    Phase 2, Completed, 107 people, May 9, 2018

Grants and prizes

  • European Research Council

    HORIZON-ERC-POC, Targeting telomeric DNA damage response as a new strategy to fight immunosenescence and improve vaccine response, 101113229, €150k, 2023–2025, Jun 6, 2023

Sources: cordis.europa.eu

Papers